Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,642.00    14.00 (0.30%)
Bid:
4,616.00
Ask:
4,622.00
Spread: 6.00 (0.13%)
Market Cap: £17.53b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

2022 AGM – Voting Results Update Statement

12 Jan 2023 07:00

RNS Number : 4597M
Halma PLC
12 January 2023
Ā 

Halma plc ('Halma')

Ā 

2022 Annual General Meeting - Voting Results Update Statement

At the Company's Annual General Meeting ("AGM") held on 21 July 2022, the total votes received in favour of Resolution 3 (Remuneration Report) was 67.14%. The total votes received in favour of Resolution 10 (the re-election of Jo Harlow, as a director) was 76.78%, and we understand from shareholders that this was linked to her role as Remuneration Committee Chair.

Given more than 20 per cent of votes were cast against these Resolutions, the Company is providing an update on the views received from shareholders and actions taken as set out under the provisions of the UK Corporate Governance Code.

Since the AGM, we have completed a thorough shareholder engagement, outlining Halma's continuing strong profit and valuation growth over the past twenty years, as well as clarifying that retention risk was part of the rationale for the variable pay and salary reset implemented over two years, in 2021 and 2022.Ā 

Ā 

The benefits of this reset were demonstrated during the period. As part of a well-planned CEO transition process over the past 12 months, Halma was able to successfully recruit an experienced FTSE 100 Group CFO, Steve Gunning, to replace Marc Ronchetti, who will be promoted to the Group CEO with effect from 1 April 2023. No further future changes were raised or requested by the shareholders with whom we met.

Ā 

The Board would like to thank all the shareholders that have taken part in the engagement and for the feedback provided. In line with our normal practice, the Board will continue to engage with shareholders and their representative bodies and will provide a final update in the 2023 Directors' Remuneration Report.

For further information, please contact:

Mark Jenkins

Company Secretary, Halma plc

Tel: +44 (0)1494 721111

Ā 

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad market areas where it operates:

Ā· Safety - Protecting people's safety and the environment as populations grow, and enhancing worker safety

Ā· Environment - Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific researchĀ 

Ā· Health - Meeting the increasing demand for better healthcare as chronic illness rises, driving by growing and ageing populations and lifestyle changes.

It employs over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
RAGUAORROKUAAUR
Date   Source Headline
28th May 20267:15 amRNSExecutive Board changes
13th Apr 20267:00 amRNSAcquisition
12th Mar 20267:00 amRNSTrading Update
13th Jan 20269:18 amRNSDirector/PDMR Shareholding
9th Jan 20261:26 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSAcquisition
5th Dec 20257:00 amRNSAcquisition
20th Nov 20257:00 amRNSHalf Year Results
1st Oct 20252:00 pmRNSDirector/PDMR Shareholding
26th Sep 202510:19 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAcquisition
24th Jul 20252:15 pmRNSResult of AGM
30th Jun 202511:30 amRNSDirector/PDMR Shareholding
25th Jun 20258:30 amRNSAGM - Revised Form of Proxy
24th Jun 20259:20 amRNSDirector/PDMR Shareholding
20th Jun 20255:15 pmRNSAnnual Financial Report
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSFull Year Results
16th May 20257:00 amRNSDirectorate Change
28th Mar 20251:10 pmRNSDirector/PDMR Shareholding
21st Mar 20252:00 pmRNSDirectorate Change
13th Mar 20257:00 amRNSTrading Update
28th Feb 20254:29 pmRNSDirector/PDMR Shareholding
14th Jan 20252:05 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSAppointment of Chief Financial Officer
28th Nov 202410:04 amRNSDirector/PDMR Shareholding
22nd Nov 20243:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:26 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSHalf Year Results
18th Nov 20247:00 amRNSAcquisition
6th Nov 20242:34 pmRNSDirector Declaration
2nd Oct 20249:20 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSTrading Update
24th Sep 20249:45 amRNSDirector/PDMR Shareholding
3rd Sep 20249:15 amRNSPDMR Shareholding
25th Jul 20241:51 pmRNSResult of AGM
24th Jul 20249:15 amRNSDirector/PDMR Shareholding
17th Jul 202412:46 pmRNSDirector Declaration
1st Jul 20249:51 amRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSAcquisition
25th Jun 20243:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:26 pmRNSAnnual Financial Report
13th Jun 20247:00 amRNSFull Year Results
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.